Stay updated on ALLAY-HF: Sacubitril/Valsartan for mild HF Clinical Trial
Sign up to get notified when there's something new on the ALLAY-HF: Sacubitril/Valsartan for mild HF Clinical Trial page.

Latest updates to the ALLAY-HF: Sacubitril/Valsartan for mild HF Clinical Trial page
- Check5 days agoChange DetectedThe Alleviant ALLAY-HF study record is displayed, with details about the heart failure trial, its eligibility and treatment plan, participating locations, and study dates.SummaryDifference100%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe study page displays a 403 Forbidden error instead of study details.SummaryDifference0.2%

- Check26 days agoChange DetectedA site-wide NIH banner announces a terminology change from “Artificial Intelligence” to “Super Intelligence,” and the site revision advances from v3.7.1 to v3.7.2. The study page continues to display a 403 error.SummaryDifference1%

- Check40 days agoChange DetectedThe footer’s site revision identifier changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check54 days agoChange Detected- Access to the study record is blocked by a 403 Forbidden page, replacing the detailed study information with an error screen. The change removes visible study details, including the study description, contacts, and locations, preventing user access to enrollment and background information.SummaryDifference20%

- Check61 days agoChange DetectedUI copy changed from 'Find Contact Information' to 'Find contact information', and the revision label updated to v3.7.0 (replacing v3.6.6).SummaryDifference0.1%

Stay in the know with updates to ALLAY-HF: Sacubitril/Valsartan for mild HF Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ALLAY-HF: Sacubitril/Valsartan for mild HF Clinical Trial page.